Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 127-71-9 | MDL No. : | MFCD00044890 |
Formula : | C13H12N2O3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PBCZLFBEBARBBI-UHFFFAOYSA-N |
M.W : | 276.31 | Pubchem ID : | 5319 |
Synonyms : |
N-Sulfanilylbenzamide;Sultrin
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 71.65 |
TPSA : | 97.64 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.49 cm/s |
Log Po/w (iLOGP) : | 1.53 |
Log Po/w (XLOGP3) : | 0.7 |
Log Po/w (WLOGP) : | 2.48 |
Log Po/w (MLOGP) : | 1.38 |
Log Po/w (SILICOS-IT) : | 0.68 |
Consensus Log Po/w : | 1.35 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.2 |
Solubility : | 1.75 mg/ml ; 0.00635 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.33 |
Solubility : | 1.3 mg/ml ; 0.0047 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.48 |
Solubility : | 0.00915 mg/ml ; 0.0000331 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.11 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 144-80-9 ]
N-((4-Aminophenyl)sulfonyl)acetamide
Similarity: 0.83
[ 127-56-0 ]
Sodium acetyl((4-aminophenyl)sulfonyl)amide
Similarity: 0.82
[ 6209-17-2 ]
Sodium acetyl((4-aminophenyl)sulfonyl)amide hydrate
Similarity: 0.82
[ 4703-15-5 ]
N-(2,6-dimethylphenyl)-4-methylbenzenesulfonamide
Similarity: 0.77
[ 22952-24-5 ]
6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide
Similarity: 0.83
[ 144-80-9 ]
N-((4-Aminophenyl)sulfonyl)acetamide
Similarity: 0.83
[ 6209-17-2 ]
Sodium acetyl((4-aminophenyl)sulfonyl)amide hydrate
Similarity: 0.82
[ 144-80-9 ]
N-((4-Aminophenyl)sulfonyl)acetamide
Similarity: 0.83
[ 127-56-0 ]
Sodium acetyl((4-aminophenyl)sulfonyl)amide
Similarity: 0.82
[ 6209-17-2 ]
Sodium acetyl((4-aminophenyl)sulfonyl)amide hydrate
Similarity: 0.82
[ 4703-15-5 ]
N-(2,6-dimethylphenyl)-4-methylbenzenesulfonamide
Similarity: 0.77
[ 22952-24-5 ]
6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide
Similarity: 0.83
[ 144-80-9 ]
N-((4-Aminophenyl)sulfonyl)acetamide
Similarity: 0.83
[ 6209-17-2 ]
Sodium acetyl((4-aminophenyl)sulfonyl)amide hydrate
Similarity: 0.82